JPS5946946B2 - Method for producing cyclopentanone derivative compounds - Google Patents

Method for producing cyclopentanone derivative compounds

Info

Publication number
JPS5946946B2
JPS5946946B2 JP10805081A JP10805081A JPS5946946B2 JP S5946946 B2 JPS5946946 B2 JP S5946946B2 JP 10805081 A JP10805081 A JP 10805081A JP 10805081 A JP10805081 A JP 10805081A JP S5946946 B2 JPS5946946 B2 JP S5946946B2
Authority
JP
Japan
Prior art keywords
reference example
solution
cis
hexenyl
carboxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP10805081A
Other languages
Japanese (ja)
Other versions
JPS57114584A (en
Inventor
カレル・フランシス・バ−ナデイ
ミドルトン・ブロウナ−・フロイド・ジユニア
ジヨン・フランク・ポレツト
ロバ−ト・ユ−ジン・スコ−ブ
マ−チン・ジヨウジフ・ウエイス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of JPS57114584A publication Critical patent/JPS57114584A/en
Publication of JPS5946946B2 publication Critical patent/JPS5946946B2/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/09Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
    • C07C29/10Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/17Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrogenation of carbon-to-carbon double or triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C07C29/38Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
    • C07C29/42Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing triple carbon-to-carbon bonds, e.g. with metal-alkynes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/62Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0025Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0033Analogues having the carboxyl group in the side-chains replaced by other functional groups containing sulfur
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04Saturated ethers
    • C07C43/12Saturated ethers containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/58Preparation of carboxylic acid halides
    • C07C51/60Preparation of carboxylic acid halides by conversion of carboxylic acids or their anhydrides or esters, lactones, salts into halides with the same carboxylic acid part
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00Compounds containing elements of Groups 1 or 11 of the Periodic System
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/06Aluminium compounds
    • C07F5/061Aluminium compounds with C-aluminium linkage
    • C07F5/062Al linked exclusively to C
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

【発明の詳細な説明】 本発明は気管支拡張剤、低血圧症用薬剤または抗潰瘍剤
として有効な11−ヒドロキシおよび11−デオキシー
9−ケト(またはヒドロキシ)プロスタン酸誘導f、を
製造するための新規な中間体化合物の製法に関するもの
である。
DETAILED DESCRIPTION OF THE INVENTION The present invention provides a method for producing 11-hydroxy and 11-deoxy-9-keto (or hydroxy) prostanoic acid derivatives useful as bronchodilators, hypotensive agents or anti-ulcer agents. This invention relates to a method for producing a novel intermediate compound.

この新規の中間体化合物は次式 であられされる化合物を、次式、 (C6H5)3P=CH−(CH2)PCOO−M+(
ここにpは2〜6の整数、M+は金属陽イオンを示す)
であられされる化合物と、ジメチルスルホキシド中で反
応せしめてシクロペンタノールを得、ついでこのシクロ
ペンタノールを酸化して相当するシクロペンタノン誘導
体化合物とすることによつて得られる。
This new intermediate compound converts the compound prepared by the following formula into the following formula: (C6H5)3P=CH-(CH2)PCOO-M+(
Here, p is an integer from 2 to 6, and M+ represents a metal cation)
It can be obtained by reacting with a compound expressed in dimethyl sulfoxide to obtain cyclopentanol, and then oxidizing this cyclopentanol to obtain the corresponding cyclopentanone derivative compound.

本発明の方法における化学反応をフローシートにより示
せば次の通9である,上記の反応順序に従えば、3,4
−エポキシラクトーノ{])〔E.J.COeryとR
.NOyOri,TetrahedrOnLetter
s,3ll(1970)〕がイリトて)で処理されて、
プロスタグランジン 2シリーズのα一鎖をもつ、3,
4−エポキシシクロペタノーノL(11?生ずる。
If the chemical reaction in the method of the present invention is shown in a flow sheet, it is as follows: 9. If the above reaction order is followed, 3, 4
-Epoxylactone {]) [E. J. COery and R
.. NOyOri, TetrahedrOnLetter
s, 3ll (1970)] was processed with Iritte),
Prostaglandin 2 series with α single chain, 3,
4-Epoxycyclopetano L (11?) is produced.

このものの酸化(例えばH2crO4・H2sO4−エ
ーテルまたはジヨーンズ試薬を用いる)はエポキシケ1
・?z生成し、さらにこれに穏和な塩基処理を加えると
まず4ヒドロキシシクロペント−2−エン一1−オンと
その異・励体3−ヒドロキシシクロベント−4エン一1
−オンMとの混合物となる。この混合物をな訃も希塩基
を用いて穏和な条件の下(好ましくはPHlO.3〜1
0.6で24時間)で処理すると3−ヒドロキシ異性体
Mが所望の目的物である4−ヒドロキシ異性体罰すべて
異性化する。本発明者らはエホキシケトン(fV)/l
)らヒドロキシシクロペンテノン(V)ぶよz鬼卜の変
換ならひに(V?・ら(■卜の異性化は3,4−ジオー
ノイWY中間段階を経て生起するものと信じている。次
に本発明の方法を参考例訃よび実施例を挙げて説明する
Oxidation of this (e.g. using H2crO4.H2sO4-ether or Johns reagent)
・? When z is produced and further treated with a mild base, 4-hydroxycyclopent-2-ene-1-one and its heteroexciter 3-hydroxycyclobent-4ene-1
-OnM becomes a mixture. This mixture is prepared using a dilute base under mild conditions (preferably PHLO.3-1
0.6 for 24 hours), the 3-hydroxy isomer M isomerized to the desired end product, the 4-hydroxy isomer. The inventors have determined that ethoxyketone (fV)/l
We believe that the isomerization of hydroxycyclopentenone (V) and hydroxycyclopentenone (V) occurs through an intermediate step of 3,4-dione WY. The method of the present invention will be explained by giving reference examples and examples.

参考例 A オールーシス−2−(6−カルボキシ−2−シスーヘキ
セニル)−3,4−オキシドーシクロぺンタノ一ルの製
造オールーシス−5−ヒドロキシ−2,3−オキシドシ
クロペンチルアセタルデヒドーγ−ラクトール(E.J
.CoreyとR.Noyori.Tetrahedr
onLetters.1970.311)1.429(
10.0ミリモル)を5m肋DMSOに溶解した溶液を
、13.39(30ミリモノ(ハ)の4−カルボキシブ
チルトリフエニルホスホニウム ブロマイドノ2.52
9(60ミリモル)の57%水素化ナトリウム分散物、
お・よび70ml(7)DMSOから調製したWitt
ig試薬〔E.J.Coreyeta1.JACS,9
1,5675(1959)〕の溶液へ撹拌しながら16
℃で1分間に加える。
Reference Example A Production of allosis-2-(6-carboxy-2-cis-hexenyl)-3,4-oxidocyclopentanol Allosis-5-hydroxy-2,3-oxidocyclopentyl acetaldehyde γ- Lactol (E.J.
.. Corey and R. Noyori. Tetrahedr
onLetters. 1970.311) 1.429(
13.39 (30 mmol) of 4-carboxybutyltriphenylphosphonium bromide 2.52
9 (60 mmol) of a 57% sodium hydride dispersion,
and 70 ml (7) of Witt prepared from DMSO.
ig reagent [E. J. Coreyeta1. JACS, 9
1,5675 (1959)] with stirring.
Add for 1 minute at ℃.

溶液を周囲温度で20時間攪拌し、塩化メチレン、氷}
よび塩酸からなる混合物に撹拌しながら注ぐ,有機相を
分離し、水相を塩化メチレンで抽出し、食塩で飽和しエ
ーテルで抽出する。
The solution was stirred at ambient temperature for 20 h, then diluted with methylene chloride, ice.
and hydrochloric acid with stirring, the organic phase is separated and the aqueous phase is extracted with methylene chloride, saturated with common salt and extracted with ether.

有機抽出物を合せて重炭酸ナトリウムで分配する。水性
塩基性抽出物を稀HCIで酸性となし、塩化ナトリウム
で飽和せしめ、酢酸エチルで抽出する。抽出物を食塩水
で洗い硫酸マグネシウム上で乾燥し濃縮すると有機油と
して粗製の表題化合物を与える参考例 B オールーシス−2−(6−カルボキシ−2−シスーヘキ
セニル)−3,4−オキシドシクロペンタノンの製造1
.6mlのエーテル中へ1.6モルの粗製オールーシス
−2−(6−カルボキシ−2−シスーヘキセニル)−3
, 4−オキシドシクロペンタノ一ル(参考例A)を溶
解した溶液を撹拌しつつ4N硫酸に4.0Nクロム酸を
溶解したもの1.6mlをO0Cで9分間に加える。
Combine the organic extracts and partition with sodium bicarbonate. The aqueous basic extract is acidified with dilute HCI, saturated with sodium chloride and extracted with ethyl acetate. Reference Example B Allcis-2-(6-carboxy-2-cis-hexenyl)-3,4-oxidocyclopentanone when the extract is washed with brine, dried over magnesium sulfate and concentrated to give the crude title compound as an organic oil. Manufacturing 1
.. 1.6 mol of crude allcis-2-(6-carboxy-2-cis-hexenyl)-3 in 6 ml of ether
, 1.6 ml of 4.0N chromic acid dissolved in 4N sulfuric acid was added to the solution containing 4-oxide cyclopentanol (Reference Example A) for 9 minutes at O0C while stirring.

O℃で5分間撹拌した後、溶液を食塩水、エーテルおよ
び酢酸エチルで稀釈する。有機相をイソプロパノ一ルで
処理し、食塩水で洗い硫酸マグネシウム上で乾燥する。
溶剤を蒸発させると油として主題化合物を与える。参考
例 C 2−(6−カルボキシ−2−シスーヘキセニル)4−ヒ
ドロキシシクロペント−2−エン−1−オンの製造オー
ルーシス−2−(6−カルボキシ−2−シスーヘキセニ
ル)−3, 4−オキシドシクロペンタノン(参考例B
)1.0ミリモルと炭酸ナトリウム3.Oミリモルを水
15mlに溶解した溶液を室温で3時間放置する。
After stirring for 5 minutes at 0° C., the solution is diluted with brine, ether and ethyl acetate. The organic phase is treated with isopropanol, washed with brine and dried over magnesium sulfate.
Evaporation of the solvent gives the title compound as an oil. Reference Example C Production of 2-(6-carboxy-2-cis-hexenyl)4-hydroxycyclopent-2-en-1-one All-cis-2-(6-carboxy-2-cis-hexenyl)-3,4-oxide Cyclopentanone (Reference example B
) 1.0 mmol and sodium carbonate3. A solution of O mmol dissolved in 15 ml of water is allowed to stand at room temperature for 3 hours.

溶液をHCIで酸性にし、塩化ナトリウムで飽和し、エ
ーテルで抽出する。抽出物を食塩水で洗い、硫酸マグネ
シウム上で乾燥し濃縮するど表題化合物と異性体化合物
、2(6−カルボキシ−2−シスーヘキセニル)−3−
ヒドロキシシクロペント−4−エン−1−オンとの混合
物を与える。この混合物を10Nカセイソーダで室温に
卦いて30分更に処理すると後者異性体が転位しで表題
化合物になり、それは上述の如く塩基性溶液から単離さ
れる。参考例 D 2−(6−カルボキシ−2−シスーヘキセニル)4−ヒ
ドロキシシクロペント−2−エン−1一オンの製造シス
−anti −シスーヒドロキシ−2, 3−オキシド
シクロペンチルアセタルデヒドーγ−ラクトール(E.
J.Coreyl:.R.Noyori.Tetra
hedronLetters.1970.311)を参
考例Aに記載する如く4−カルボキシブチルトリフエニ
ルホスホニウム ブロマイドで処理すると2β−(6−
カルボキシ−2−シスーヘキセニル)3α,4α−オキ
シドシクロペンタン−1β−オールを生じ、このものは
参考例Bの方法で酸化すると2β−(6−カルボキシ−
2−シスーヘキセニル)−3α,4α−オキシドシクロ
ペンタノンを与え、このものは結局参考例Cの方法で水
性塩基で処埋すると主題化合物を与える。
The solution is acidified with HCI, saturated with sodium chloride and extracted with ether. The extracts were washed with brine, dried over magnesium sulfate, and concentrated to yield the title compound and isomeric compounds, 2(6-carboxy-2-cis-hexenyl)-3-
to give a mixture with hydroxycyclopent-4-en-1-one. Further treatment of this mixture with 10N caustic soda at room temperature for 30 minutes rearranges the latter isomer to give the title compound, which is isolated from the basic solution as described above. Reference Example D Production of 2-(6-carboxy-2-cis-hexenyl)4-hydroxycyclopent-2-ene-1-one cis-anti-cis-hydroxy-2,3-oxidecyclopentyl acetaldehyde γ- Lactol (E.
J. Coreyl:. R. Noyori. Tetra
hedronLetters. 1970.311) with 4-carboxybutyltriphenylphosphonium bromide as described in Reference Example A, 2β-(6-
carboxy-2-cis-hexenyl)3α,4α-oxidecyclopentan-1β-ol, which when oxidized by the method of Reference Example B gives 2β-(6-carboxy-
2-cis-hexenyl)-3α,4α-oxide cyclopentanone which, when eventually treated with aqueous base in the manner of Reference Example C, gives the title compound.

参考例 E 4 −カルボキシブチルトリフエニルホスホニウム ブ
ロマイドの製造5−ブロモ吉草酸1039とトリフエニ
ルホスフイン1529とのアセトニトリル400ml中
での混合物を48時間還流し、冷却し、1007nlの
ベンゼンで稀釈し放置して結晶させる。
Reference Example E Preparation of 4-carboxybutyltriphenylphosphonium bromide A mixture of 5-bromovaleric acid 1039 and triphenylphosphine 1529 in 400 ml of acetonitrile was refluxed for 48 hours, cooled, diluted with 1007 nl of benzene and allowed to stand. and crystallize it.

結晶を沢過しベンゼンとエーテルとで洗うとM.p.2
O7−209℃の無色物質を生成する。参考例 F−H 表1の表示されたω−ブロモアルカン酸をトリフエニル
ホスフインで参考例Eに記載する方法ご処理すると表の
ホスホニウム ブロマイドを生成する。
When the crystals are filtered and washed with benzene and ether, M. p. 2
Produces a colorless material at 07-209°C. Reference Examples F-H When the ω-bromoalkanoic acids shown in Table 1 are treated with triphenylphosphine according to the method described in Reference Example E, the phosphonium bromides shown in the table are produced.

参考例 1−K オール シス一5−ヒドロキシ−2,3−オキシドシク
ロペンチルアセタルデヒドーラクトールを表の表示した
ホスホニウム ブロマイドから調製したWittig試
薬で総て参考例Aの方法V(より処理すると表の生成物
を生ずる。
Reference Example 1-K All cis-5-hydroxy-2,3-oxide cyclopentyl acetal dehydrol lactol was treated with the Wittig reagent prepared from the phosphonium bromide shown in the table by Method V of Reference Example A (see Table 1). of the product.

々4i1=+士 参考例 0−Q 下記表4の3,4−オキシドシクロペンタノンを参考例
Cに記載された方法によりアルカリ処理すると表の4−
ヒドロキシシクロペンチノンを生ずる。
4i1 = + Reference Example 0-Q When 3,4-oxidocyclopentanone in Table 4 below is treated with alkali by the method described in Reference Example C, 4- in Table 4-
Produces hydroxycyclopentynone.

参考例 R 4−デトラヒドロピラニルオキシ一2−(6テトラヒド
ロピラニルカルボキシヘキシル)シクロペント−2−エ
ン一1−オンの製造100m1のメチレンクロリツドに
5.599(24.6ミリモル)の4−ヒドロキシ−2
−(6−カルボキシヘキシル)シクロペント−2−エン
1−オンと20.79(246ミリモル)のジヒドロピ
ランとを溶かした撹拌溶液に、47〜(0.246ミリ
モル)のp−トルエンスルホン酸一水和物を20℃で一
度に加える,冷却することによつて温度を2『−25℃
に維持し、この温度に}いて1時間撹拌する。
Reference Example R Preparation of 4-detrahydropyranyloxy-2-(6tetrahydropyranylcarboxyhexyl)cyclopent-2-en-1-one 5.599 (24.6 mmol) was added to 100 ml of methylene chloride. 4-hydroxy-2
-(6-carboxyhexyl)cyclopent-2-ene 1-one and 20.79 (246 mmol) of dihydropyran are added to a stirred solution of 47 to (0.246 mmol) of p-toluenesulfonic acid monohydrate. Add the mixture at 20°C and reduce the temperature to 2'-25°C by cooling.
and stir at this temperature for 1 hour.

この溶液を200m1のエーテルで稀釈し、40m1の
飽和重曹溶液、40aの飽和塩化ナトリウム溶液および
80m1の水の混合物に注ぐ。相を分離し、その水相を
新たなエーテルで抽出する。全抽出物を引きつづき水ど
飽和塩化ナトリウム溶液で洗い、炭酸カリ上で乾燥し、
減圧下に濃縮することvこよつて揮発性物質を除くと油
状物が得られる。その性質は次の通ジである。MeOH λ =223mμ(9500);νMax.max
.l73O(エステルカルボニル基),1705(ケト
ンカルボニル基)、}よび1030C7rL−1(テト
ラヒドロピラニルオキシ基)。
This solution is diluted with 200 ml of ether and poured into a mixture of 40 ml of saturated sodium bicarbonate solution, 40a of saturated sodium chloride solution and 80 ml of water. The phases are separated and the aqueous phase is extracted with fresh ether. The entire extract was subsequently washed with water and saturated sodium chloride solution, dried over potassium carbonate,
The volatiles are removed by concentration under reduced pressure to give an oil. Its properties are as follows. MeOH λ = 223 mμ (9500); νMax. max
.. l73O (ester carbonyl group), 1705 (ketone carbonyl group),} and 1030C7rL-1 (tetrahydropyranyloxy group).

参考例 S−V 下記表5に表示された4−ヒドロキシシクロペント−2
−エン一1−オンを(参考例Rのように)ジヒドロピラ
ンで処理すると表の対応するビステトラヒドロピラニル
エーテル−エステルを生じる。
Reference example SV 4-hydroxycyclopent-2 shown in Table 5 below
Treatment of -en-1-one with dihydropyran (as in Reference Example R) yields the corresponding bis-tetrahydropyranyl ether-esters of the table.

参考例 X 4−(トリメチルシロキシ)−2−(6−カルボトリメ
チルシロキシヘキシル)シクロペント2−エン一1−オ
ンの製造乾燥N,N−ジメチルホルムアミド10m1に
2(6−カルボキシヘキシル)−4−ヒドロキシシクロ
ペント−2−エン一1−オン5f!を溶かした溶液に窒
素雰囲気中で塩化トリメチルシリル5.49を加えた。
Reference Example Cyclopent-2-en-1-one 5f! 5.49 ml of trimethylsilyl chloride was added to the solution in a nitrogen atmosphere.

得られた溶液を水道水の浴で冷却し、そしてN,N−ジ
メチルホルムアミド10m1中のトリエチルアミン5.
059を滴加した。得られた混合物を油浴中、60℃で
2時間次いで周囲の温度で18時間撹拌した。トリエチ
ルアミン塩酸塩を沢過で除き、そして沢液を乾燥状態に
至らせた。残渣油を蒸留すると、沸点156〜157。
C(0.07mm)の製品2.69が得られた。参考例
Y4−(ジメチルイソプロピルシロキシ)−2(6−
カルボジメチルイソプロピルシロキシヘキシル)シクロ
ペント−2−エン一1−オンの製造塩化ジメチルイソプ
ロピルシリル〔E.J.COrey.R.K.VaIr
na.J..Amer.Ch8n.SOc.,93,7
32O(1971)〕1.81yを含む乾燥N,N−ジ
メチルホルムアミド2m1中の2−(6−カルボキシヘ
キシル)−4−ヒドロキシシクロペント−2−エン一1
−オンを参考例Xに記載した方法によりN,N−ジメチ
ルホルムアミド2m1中のトリエチルアミン1.579
で処理すると、トルエンによる2回の蒸留の後に製品1
.459が得られる。
The resulting solution was cooled in a bath of tap water and 5.5% of triethylamine in 10 ml of N,N-dimethylformamide was added.
059 was added dropwise. The resulting mixture was stirred in an oil bath at 60° C. for 2 hours and then at ambient temperature for 18 hours. The triethylamine hydrochloride was filtered off and the sap was allowed to dry. When the residual oil is distilled, it has a boiling point of 156-157.
A product of 2.69 C (0.07 mm) was obtained. Reference example Y4-(dimethylisopropylsiloxy)-2(6-
Preparation of cyclopent-2-en-1-one (carbodimethylisopropylsiloxyhexyl)dimethylisopropylsilyl chloride [E. J. Corey. R. K. VaIr
na. J. .. Amer. Ch8n. SOc. ,93,7
32O (1971)] 2-(6-carboxyhexyl)-4-hydroxycyclopent-2-ene in 2 ml of dry N,N-dimethylformamide containing 1.81y.
-one in 2 ml of N,N-dimethylformamide by the method described in Reference Example X.
After two distillations with toluene, the product 1
.. 459 is obtained.

参考例 Z 4−(ジメチル−t−ブチルシロキシ)−2一(6−カ
ルボジメチル−t−ブチルシロキシヘキシル)シクロペ
ント−2−エン一1−オンの製造ジメチルホルムアミド
5m1に4−ヒドロキシ−2−(6−カルボキシヘキシ
ル)シクロペント一2−エン一1−オン(2−(6−カ
ルボキシヘキシル)−4−ヒドロキシ−シクロペント−
2−エリリン一1−オン)2.09(8.55モル)と
イミダゾール3.65g(54モル)とを浴解したO℃
の溶液へジメチルホルムアミド5m1中のジメチル−t
−ブチルクロロシラン4.079(27モル)からなる
スラリーを加える。
Reference Example Z Production of 4-(dimethyl-t-butylsiloxy)-2-(6-carbodimethyl-t-butylsiloxyhexyl)cyclopent-2-en-1-one 4-hydroxy-2-( 6-carboxyhexyl)cyclopent-2-en-1-one (2-(6-carboxyhexyl)-4-hydroxy-cyclopent-
2-eryrin-1-one) 2.09 (8.55 mol) and imidazole 3.65 g (54 mol) were dissolved in a bath at 0°C.
dimethyl-t in 5 ml of dimethylformamide to a solution of
- Add a slurry consisting of 4.079 (27 moles) of butylchlorosilane.

ジメチルホルムアミド1m1を加えてスラ一りを流し込
む。氷浴を除き溶液を37℃で4時間撹拌する。次いで
溶液を140dの水へ注ぎ水溶液を2回70m1の異性
体ヘキサンで抽出する。有機層を合わせて硫酸マグネシ
ウムで乾燥し真空中で濃縮して油にする。トルエン(5
0m1)を2度加えて真空中で蒸発させて不要の低温で
沸騰する不純物を除く。残渣を一夜真空下に保つと3.
389(7.45モル)の油を与え、このものは赤外部
にヒドロキシルあ・よひカルボキシル吸収を示さない。
Add 1 ml of dimethylformamide and pour in the slurry. Remove the ice bath and stir the solution at 37°C for 4 hours. The solution is then poured into 140 d of water and the aqueous solution is extracted twice with 70 ml of isomeric hexane. The organic layers are combined, dried over magnesium sulfate, and concentrated in vacuo to an oil. Toluene (5
0ml) twice and evaporated in vacuum to remove unnecessary impurities that boil at low temperatures. 3. Keep the residue under vacuum overnight.
389 (7.45 mol) of oil which shows no hydroxyl or carboxyl absorption in the infrared.

0max:1720C71L−1 (不飽和ケトンとシ
リルエステル)、840,815,795,780cT
n−1(シリルエーテルとシリルエステル)。
0max: 1720C71L-1 (unsaturated ketone and silyl ester), 840,815,795,780cT
n-1 (silyl ether and silyl ester).

参考例 A1 −E1 下記第6表に示された4−ヒドロキシシクロペント−2
−エン一1−オンを参考例Xvこ記載した方法により表
示された塩化トリアルキルシリルで処理すると表のビス
ートリアルキルシリ.ルエーテルーエステルを生ずる。
Reference example A1 -E1 4-hydroxycyclopent-2 shown in Table 6 below
-En-1-one was treated with the trialkylsilyl chloride indicated in the method described in Reference Example Xv to give the bistrilkylsilyl chloride shown in the table. yields ether-ester.

実施例 1 2−(6−カルボキシ−2−シスーヘキセニル)3,4
−オキシドーシクロペンタノ一ルの製造5−ヒドロキシ
−2, 3−オキシドシクロペンチルアセトアルデヒド
ーγ−ラクトール(異性体混合物:E. J.Core
yとR.Noyori.TetrahedronLet
ters.1970.311)5.09(35ミリモノ
(ハ)をDMSO25mlに溶解した溶液を、4−カル
ボキシブチルトリフエニルホスホニウムブロマイド23
.59(53ミリモノ(ハ)、57%水素化ナトリウム
分散液6.19(140ミリモノ(ハ)卦よびDMSO
(ジメチルスルホキシド)230mlから調製したWi
ttig試薬〔E.J.Coreyetal.JACS
,91,5675(1969)〕とジムシルナトリウム
からなる撹拌溶液中にO.5分間20℃で加える。
Example 1 2-(6-carboxy-2-cis-hexenyl)3,4
-Production of oxidocyclopentanol 5-hydroxy-2,3-oxidocyclopentylacetaldehyde γ-lactol (isomer mixture: E. J. Core
y and R. Noyori. Tetrahedron Let
ters. 1970.311) 5.09 (35 mm) A solution of 25 ml of DMSO was dissolved in 4-carboxybutyl triphenylphosphonium bromide 23
.. 59 (53 mmol), 57% sodium hydride dispersion 6.19 (140 mmol) and DMSO
Wi prepared from 230 ml (dimethyl sulfoxide)
ttig reagent [E. J. Coreyetal. JACS
, 91, 5675 (1969)] and dimsyl sodium. Add for 5 minutes at 20°C.

溶液を周囲温度で2時間撹拌し、これを塩化メチレン、
水、卦よび塩酸の混合物を攪拌しその中に注ぐ。
The solution was stirred at ambient temperature for 2 hours and then diluted with methylene chloride,
Stir the mixture of water, hexagrams and hydrochloric acid and pour into it.

反応混合物は参考例Aに記載される如く仕上げられ粗生
成物はシリカゲル上のドライカラムクロマトグラフイー
による精製されて表題化合物(2つの立体異性体の混合
物)を油として与える。IR(フイルム)3540,
1710,および832儂−1実施例 2 2−(6−カルボキシ−2−シスーヘキセニル)−3,
4−オキシドシクロペンタノンの製造アセトン66m
l中に2−(6−カルボキシ−2シスーヘキセニル)−
3, 4−オキシドシクロペンタノ一ル(実施例1)2
.989(13.2ミリモル)を溶解した溶液を撹拌し
これを、8NM2S04中の8Nクロム酸3.30ml
で20分間−10ないし−5℃で1滴ずつ処理する。
The reaction mixture is worked up as described in Reference Example A and the crude product is purified by dry column chromatography on silica gel to give the title compound (a mixture of two stereoisomers) as an oil. IR (film) 3540,
1710, and 832儂-1 Example 2 2-(6-carboxy-2-cis-hexenyl)-3,
Production of 4-oxide cyclopentanone Acetone 66m
2-(6-carboxy-2cis-hexenyl)-
3,4-oxide cyclopentanol (Example 1) 2
.. A stirred solution of 989 (13.2 mmol) was added to 3.30 ml of 8N chromic acid in 8NM2S04.
Treat drop by drop at -10 to -5°C for 20 minutes.

Claims (1)

【特許請求の範囲】 1 次式 ▲数式、化学式、表等があります▼ で表わされる化合物の1モルを次式 (C_6H_5)_3P=CH−(CH_2)_pCO
O^−M^+(ここにpは2〜6の整数、M^+は金属
陽イオンを示す)で表わされる化合物の過剰モル量と常
温下にジメチルスルホキシド中で反応せしめて目的化合
物に対応するシクロペンタノールを生成せしめた後、ク
ロム酸H_2CrO_4と硫酸の溶液で酸化してその対
応するシクロペンタノンを生成せしめ、このものを反応
混合物中から分離することを特徴とする次式▲数式、化
学式、表等があります▼ (ここにpは前記の通りである) で表わされるシクロペンタノン誘導体化合物の製法。
[Claims] One mole of a compound represented by the primary formula ▲ There are mathematical formulas, chemical formulas, tables, etc.
The desired compound is obtained by reacting an excess molar amount of a compound represented by O^-M^+ (where p is an integer of 2 to 6, M^+ indicates a metal cation) in dimethyl sulfoxide at room temperature. After the cyclopentanol is produced, it is oxidized with a solution of chromic acid H_2CrO_4 and sulfuric acid to produce the corresponding cyclopentanone, which is separated from the reaction mixture. There are chemical formulas, tables, etc. ▼ (where p is as above) A method for producing a cyclopentanone derivative compound represented by.
JP10805081A 1972-07-24 1981-07-10 Method for producing cyclopentanone derivative compounds Expired JPS5946946B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27476872A 1972-07-24 1972-07-24
US274768 1988-11-22

Publications (2)

Publication Number Publication Date
JPS57114584A JPS57114584A (en) 1982-07-16
JPS5946946B2 true JPS5946946B2 (en) 1984-11-15

Family

ID=23049539

Family Applications (3)

Application Number Title Priority Date Filing Date
JP8351773A Pending JPS4985049A (en) 1972-07-24 1973-07-24
JP10805181A Pending JPS57131737A (en) 1972-07-24 1981-07-10 Manufacture of cyclopentanone derivative
JP10805081A Expired JPS5946946B2 (en) 1972-07-24 1981-07-10 Method for producing cyclopentanone derivative compounds

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP8351773A Pending JPS4985049A (en) 1972-07-24 1973-07-24
JP10805181A Pending JPS57131737A (en) 1972-07-24 1981-07-10 Manufacture of cyclopentanone derivative

Country Status (7)

Country Link
JP (3) JPS4985049A (en)
BE (1) BE802718A (en)
CA (1) CA1049022A (en)
DE (1) DE2337343A1 (en)
FR (1) FR2193614B1 (en)
GB (1) GB1444963A (en)
NL (1) NL7310277A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172953A (en) * 1973-03-30 1979-10-30 G. D. Searle & Co. 2,3,5-Trisubstituted cyclopentanealkenoic acids, derivatives thereof and intermediates thereto
EP1585729A1 (en) * 2003-01-10 2005-10-19 F.Hoffmann-La Roche Ag 2-piperidone derivatives as prostaglandin agonists

Also Published As

Publication number Publication date
AU5831073A (en) 1975-01-23
CA1049022A (en) 1979-02-20
BE802718A (en) 1974-01-24
DE2337343A1 (en) 1974-03-14
NL7310277A (en) 1974-01-28
JPS57114584A (en) 1982-07-16
FR2193614B1 (en) 1977-04-22
GB1444963A (en) 1976-08-04
JPS4985049A (en) 1974-08-15
JPS57131737A (en) 1982-08-14
FR2193614A1 (en) 1974-02-22

Similar Documents

Publication Publication Date Title
CA1201712A (en) Carbacyclin analogs
JPH0153672B2 (en)
US4668814A (en) Interphenylene carbacyclin derivatives
US4683330A (en) Interphenylene carbacyclin derivatives
CA1241324A (en) Interphenylene carbacyclin derivatives
NO144385B (en) INTERMEDIATE FOR THE PREPARATION OF NEW PENTANOR PROSTAGLANDINES OF THE E OR F SERIES
JPH0451538B2 (en)
US4035415A (en) Omega-nor-cycloalkyl-13,14-dehydro-prostaglandins
JPH0368849B2 (en)
JPS5946946B2 (en) Method for producing cyclopentanone derivative compounds
EP0065638B1 (en) Substituted 7-(4-substituted-cyclopent-2-en-1-on-2-yl)-hept-2-transenoates
JPS5846510B2 (en) 13,14-dehydro-11-deoxy-prostaglandin and its production method
US4983753A (en) Precursors and synthesis of di-(methyl)-16,16-(dimethyl)-11-alpha,15-alpha beta-dihydroxy-9-oxo-2,13-trans,trans-prostadienoates
JPH0141142B2 (en)
JPH0414091B2 (en)
JPS5921864B2 (en) Fluoroprostaglandins and their production method
US4474979A (en) Synthesis of d1-(methyl)-16,16-(dimethyl-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans,trans-prostadienoates
JP2869139B2 (en) Method for producing steroid derivative
JPS646181B2 (en)
JP2856838B2 (en) Method for producing steroid derivative
US5166369A (en) Precursors and synthesis of D1-(methyl)-16,16-(dimethyl)-11-alpha, 15-alpha, beta-dihydroxy-9-oxo-2,13,-trans, trans-prostadienoates
CA1313670C (en) Carbacyclin analogs
US4046787A (en) Novel 15-substituted prostanoic acids and esters
CA1209154A (en) Intermediates for preparing 9-hydroxy substituted carbacyclin derivatives
JP3228486B2 (en) Hydroxyketone derivative and method for producing the same